Figure 1‑1: Interventional Cardiology Device Market Share Ranking by Segment, Europe, 2022 (1 of 3) |
Figure 1‑2: Interventional Cardiology Device Market Share Ranking by Segment, Europe, 2022 (2 of 3) |
Figure 1‑3: Interventional Cardiology Device Market Share Ranking by Segment, Europe, 2022 (3 of 3) |
Figure 1‑4: Companies Researched in This Report |
Figure 1‑5: Factors Impacting the Interventional Cardiology Device Market by Segment, Europe (1 of 3) |
Figure 1‑6: Factors Impacting the Interventional Cardiology Device Market by Segment, Europe (2 of 3) |
Figure 1‑7: Factors Impacting the Interventional Cardiology Device Market by Segment, Europe (3 of 3) |
Figure 1‑8: Recent Events in the Interventional Cardiology Device Market, Europe, 2019 – 2023 (1 of 2) |
Figure 1‑9: Recent Events in the Interventional Cardiology Device Market, Europe, 2019 – 2023 (2 of 2) |
Figure 1‑10: Interventional Cardiology Procedures Covered, Europe |
Figure 1‑11: Interventional Cardiology Device Markets Covered, Europe |
Figure 1‑12: Key Report Updates |
Figure 1‑13: Version History |
Figure 2‑1: Europe Interventional Cardiology Device Market by Segment, Worst Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2) |
Figure 2‑2: Europe Interventional Cardiology Device Market by Segment, Worst Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2) |
Figure 2‑3: Europe Interventional Cardiology Device Market by Segment, Base Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2) |
Figure 2‑4: Europe Interventional Cardiology Device Market by Segment, Base Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2) |
Figure 2‑5: Europe Interventional Cardiology Device Market by Segment, Best Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2) |
Figure 2‑6: Europe Interventional Cardiology Device Market by Segment, Best Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2) |
Figure 4‑1: Coronary Stents by Company |
Figure 4‑2: Coronary Balloon Catheters by Company |
Figure 4‑3: Interventional Coronary Catheters by Company |
Figure 4‑4: Interventional Coronary Guidewires by Company |
Figure 4‑5: Coronary Embolic Protection Devices by Company |
Figure 4‑6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company |
Figure 4‑7: Coronary Chronic Total Occlusion Devices by Company |
Figure 4‑8: Coronary Introducer Sheaths by Company (1 of 2) |
Figure 4‑9: Coronary Introducer Sheaths by Company (2 of 2) |
Figure 4‑10: Coronary Vascular Closure Devices by Company |
Figure 4‑11: Diagnostic Coronary Catheters & Guidewires by Company |
Figure 4‑12: Coronary Intravascular Ultrasound Devices by Company |
Figure 4‑13: Coronary Optical Coherence Tomography by Company |
Figure 4‑14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm |
Figure 4‑15: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System |
Figure 4‑16: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System |
Figure 4‑17: Class 2 Device Recall Cordis Precise Nitinol Stent System |
Figure 4‑18: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System |
Figure 4‑19: Class 1 Device Recall NC TREK Coronary Dilatation Catheter |
Figure 4‑20: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter |
Figure 4‑21: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters |
Figure 4‑22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter |
Figure 4‑23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter |
Figure 4‑24: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter |
Figure 4‑25: Class 2 Device Recall MAMBA Flex 135 Microcatheter |
Figure 4‑26: Class 2 Device Recall MAMBA Microcatheter |
Figure 4‑27: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters |
Figure 4‑28: Class 2 Device Recall Guidezilla II Guide Extension Catheter |
Figure 4‑29: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter |
Figure 4‑30: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER |
Figure 4‑31: Class 1 Device Recall 6F Taiga Guiding Catheter |
Figure 4‑32: Class 2 Device Recall Destination Guiding Sheath |
Figure 4‑33: Class 2 Device Recall Stingray" Guidewire |
Figure 4‑34: Class 2 Device Recall Boston Scientific ROTAPRO |
Figure 4‑35: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM |
Figure 4‑36: Class 1 Device Recall TurboHawk Plus |
Figure 4‑37: Class 1 Device Recall HawkOne |
Figure 4‑38: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER |
Figure 4‑39: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS |
Figure 4‑40: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER |
Figure 4‑41: Class 2 Device Recall Microintroducer Kit |
Figure 4‑42: Class 2 Device Recall |
Figure 4‑43: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification |
Figure 4‑44: Class 2 Device Recall Flexor CheckFlo Introducer |
Figure 4‑45: Class 1 Device Recall Flexor CheckFlo Introducer |
Figure 4‑46: Class 2 Device Recall Avanti Catheter Sheath Introducer |
Figure 4‑47: Class 2 Device Recall Prelude Short Sheath Introducer |
Figure 4‑48: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer |
Figure 4‑49: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System |
Figure 4‑50: Class 1 Device Recall Portico Solo ReCollapsible Access System |
Figure 4‑51: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices |
Figure 4‑52: Class 2 Device Recall AngioSeal Evolution |
Figure 4‑53: Class 1 Device Recall Imager II 5F Angiographic Catheter |
Figure 4‑54: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter |
Figure 4‑55: Class 2 Device Recall iLab Polaris MultiModality Guidance System |
Figure 4‑56: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN) |
Figure 4‑57: RESOLUTE ONYX China Single Arm Study |
Figure 4‑58: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48) |
Figure 4‑59: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System |
Figure 4‑60: PROMUS PREMIER™ China Post-Approval Study |
Figure 4‑61: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) |
Figure 4‑62: China Resolute Integrity 34/38 mm Study |
Figure 4‑63: ILUMIEN IV: OPTIMAL PCI |
Figure 4‑64: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) |
Figure 4‑65: RESOLUTE ONYX Post-Approval Study (ONYX PAS) |
Figure 4‑66: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V) |
Figure 4‑67: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48) |
Figure 4‑68: Sirolimus DEB in Coronary Bifurcation Lesions |
Figure 4‑69: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV) |
Figure 4‑70: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF) |
Figure 4‑71: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST) |
Figure 4‑72: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater |
Figure 4‑73: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I) |
Figure 4‑74: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease |
Figure 4‑75: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases |
Figure 4‑76: FIRE AND ICE II Trial Pilot |
Figure 4‑77: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD) |
Figure 4‑78: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First) |
Figure 4‑79: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI) |
Figure 4‑80: Pressure Guidewire Comparison |
Figure 4‑81: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2) |
Figure 4‑82: transShield Embolic Protection System Feasibility Study |
Figure 4‑83: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation |
Figure 4‑84: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis |
Figure 4‑85: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s |
Figure 4‑86: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT) |
Figure 4‑87: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT) |
Figure 4‑88: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD) |
Figure 4‑89: Chronic Total Occlusion Registry |
Figure 4‑90: Safety and Efficacy Study of the SoundBite™ Crossing System With ACTIVE Wire in Coronary CTOs. (ACTIVE) |
Figure 4‑91: Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity |
Figure 4‑92: Clinical Study Evaluating Use of the CapBuster Medical Device System for the Crossing of Chronic Total Occlusions (CapBuster) |
Figure 4‑93: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial |
Figure 4‑94: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF) |
Figure 4‑95: Application of Vascular Closure Device in Transvenous Cardiac Intervention |
Figure 4‑96: Comparison of Different Vascular Closure Device in TAVI |
Figure 4‑97: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease |
Figure 4‑98: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE) |
Figure 4‑99: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial |
Figure 4‑100: Vascular Closure Device in Transcatheter Aortic Valve Replacement |
Figure 4‑101: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) |
Figure 4‑102: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES) |
Figure 4‑103: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System |
Figure 4‑104: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) |
Figure 4‑105: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER) |
Figure 4‑106: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS) |
Figure 4‑107: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP) |
Figure 4‑108: The OPTIMAL Randomized Controlled Trial |
Figure 4‑109: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite) |
Figure 4‑110: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES) |
Figure 4‑111: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS) |
Figure 4‑112: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB) |
Figure 4‑113: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography |
Figure 4‑114: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM) |
Figure 4‑115: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging |
Figure 5‑1: Currency Exchange Rate, 2022 |
Figure 5‑2: Europe Interventional Cardiology Device Market by Segment, Europe, 2019 – 2029 (€M) (1 of 2) |
Figure 5‑3: Europe Interventional Cardiology Device Market by Segment, Europe, 2019 – 2029 (US$M) (2 of 2) |
Figure 5‑4: Leading Competitors, Europe Interventional Cardiology Device Market, Europe, 2022 (1 of 2) |
Figure 5‑5: Leading Competitors, Europe Interventional Cardiology Device Market, Europe, 2022 (2 of 2) |
Figure 5‑6: SWOT Analysis, Abbott (1 of 2) |
Figure 5‑7: SWOT Analysis, Abbott (2 of 2) |
Figure 5‑8: SWOT Analysis, Asahi Intecc |
Figure 5‑9: SWOT Analysis, Boston Scientific |
Figure 5‑10: SWOT Analysis, Cordis |
Figure 5‑11: SWOT Analysis, Cook Medical |
Figure 5‑12: SWOT Analysis, Medtronic |
Figure 5‑13: SWOT Analysis, Penumbra |
Figure 5‑14: SWOT Analysis, Philips |
Figure 5‑15: SWOT Analysis, Teleflex |
Figure 5‑16: SWOT Analysis, Terumo |
Figure 7‑1: Interventional Cardiology Device Procedure by Segment, Europe, 2019 – 2029 (1 of 2) |
Figure 7‑2: Interventional Cardiology Device Procedure by Segment, Europe, 2019 – 2029 (2 of 2) |
Figure 7‑3: Angiography Procedures by Approach, Europe, 2019 – 2029 |
Figure 7‑4: Angiography Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑5: Radial Angiography Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑6: Femoral Angiography Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑7: Angioplasty/PCI Procedures by Approach, Europe, 2019 – 2029 |
Figure 7‑8: Angioplasty/PCI Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑9: Radial Angioplasty/PCI Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑10: Femoral Angioplasty/PCI Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑11: Coronary Atherectomy and Intravascular Lithotripsy Procedures by Type, Europe, 2019 – 2029 |
Figure 7‑12: Coronary Atherectomy Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑13: Coronary CTO Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑14: SVG Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑15: FFR Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑16: Coronary IVUS Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑17: Coronary OCT Procedures by Country, Europe, 2019 – 2029 |
Figure 7‑18: Catheterization Procedures by Country, Europe, 2019 – 2029 |
Figure 8‑1: Coronary Stent Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 8‑2: Coronary Stent Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 8‑3: Total Coronary Stent Market, Europe, 2019 – 2029 |
Figure 8‑4: Units Sold by Country, Total Coronary Stent Market, Europe, 2019 – 2029 |
Figure 8‑5: Average Selling Price by Country, Total Coronary Stent Market, Europe, 2019 – 2029 (€) |
Figure 8‑6: Average Selling Price by Country, Total Coronary Stent Market, Europe, 2019 – 2029 (US$) |
Figure 8‑7: Market Value by Country, Total Coronary Stent Market, Europe, 2019 – 2029 (€M) |
Figure 8‑8: Market Value by Country, Total Coronary Stent Market, Europe, 2019 – 2029 (US$M) |
Figure 8‑9: Bare-Metal Stent Market, Europe, 2019 – 2029 |
Figure 8‑10: Units Sold by Country, Bare-Metal Stent Market, Europe, 2019 – 2029 |
Figure 8‑11: Average Selling Price by Country, Bare-Metal Stent Market, Europe, 2019 – 2029 (€) |
Figure 8‑12: Average Selling Price by Country, Bare-Metal Stent Market, Europe, 2019 – 2029 (US$) |
Figure 8‑13: Market Value by Country, Bare-Metal Stent Market, Europe, 2019 – 2029 (€M) |
Figure 8‑14: Market Value by Country, Bare-Metal Stent Market, Europe, 2019 – 2029 (US$M) |
Figure 8‑15: Drug-Eluting Stent Market, Europe, 2019 – 2029 |
Figure 8‑16: Units Sold by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 |
Figure 8‑17: Average Selling Price by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (€) |
Figure 8‑18: Average Selling Price by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (US$) |
Figure 8‑19: Market Value by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (€M) |
Figure 8‑20: Market Value by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (US$M) |
Figure 8‑21: Covered Stent Market, Europe, 2019 – 2029 |
Figure 8‑22: Units Sold by Country, Covered Stent Market, Europe, 2019 – 2029 |
Figure 8‑23: Average Selling Price by Country, Covered Stent Market, Europe, 2019 – 2029 (€) |
Figure 8‑24: Average Selling Price by Country, Covered Stent Market, Europe, 2019 – 2029 (US$) |
Figure 8‑25: Market Value by Country, Covered Stent Market, Europe, 2019 – 2029 (€M) |
Figure 8‑26: Market Value by Country, Covered Stent Market, Europe, 2019 – 2029 (US$M) |
Figure 8‑27: Bifurcated Stent Market, Europe, 2019 – 2029 |
Figure 8‑28: Units Sold by Country, Bifurcated Stent Market, Europe, 2019 – 2029 |
Figure 8‑29: Average Selling Price by Country, Bifurcated Stent Market, Europe, 2019 – 2029 (€) |
Figure 8‑30: Average Selling Price by Country, Bifurcated Stent Market, Europe, 2019 – 2029 (US$) |
Figure 8‑31: Market Value by Country, Bifurcated Stent Market, Europe, 2019 – 2029 (€M) |
Figure 8‑32: Market Value by Country, Bifurcated Stent Market, Europe, 2019 – 2029 (US$M) |
Figure 8‑33: Leading Competitors, Coronary Stent Market, Europe, 2022 |
Figure 8‑34: Leading Competitors by Country, Coronary Stent Market, Europe, 2022 |
Figure 9‑1: Coronary Balloon Catheter Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 9‑2: Coronary Balloon Catheter Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 9‑3: Coronary Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑4: Units Sold by Country, Total Coronary Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑5: Average Selling Price by Country, Total Coronary Balloon Catheter Market, Europe, 2019 – 2029 (€) |
Figure 9‑6: Average Selling Price by Country, Total Coronary Balloon Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 9‑7: Market Value by Country, Total Coronary Balloon Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 9‑8: Market Value by Country, Total Coronary Balloon Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 9‑9: PTCA Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑10: Units Sold by Country, PTCA Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑11: Average Selling Price by Country, PTCA Balloon Catheter Market, Europe, 2019 – 2029 (€) |
Figure 9‑12: Average Selling Price by Country, PTCA Balloon Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 9‑13: Market Value by Country, PTCA Balloon Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 9‑14: Market Value by Country, PTCA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 9‑15: Drug-Eluting Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑16: Units Sold by Country, Drug-Eluting Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑17: Average Selling Price by Country, Drug-Eluting Balloon Catheter Market, Europe, 2019 – 2029 (€) |
Figure 9‑18: Average Selling Price by Country, Drug-Eluting Balloon Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 9‑19: Market Value by Country, Drug-Eluting Balloon Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 9‑20: Market Value by Country, Drug-Eluting Balloon Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 9‑21: Specialty Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑22: Units Sold by Country, Specialty Balloon Catheter Market, Europe, 2019 – 2029 |
Figure 9‑23: Average Selling Price by Country, Specialty Balloon Catheter Market, Europe, 2019 – 2029 (€) |
Figure 9‑24: Average Selling Price by Country, Specialty Balloon Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 9‑25: Market Value by Country, Specialty Balloon Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 9‑26: Market Value by Country, Specialty Balloon Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 9‑27: Leading Competitors, Coronary Balloon Catheter Market, Europe, 2022 |
Figure 9‑28: Leading Competitors by Country, Coronary Balloon Catheter Market, Europe, 2022 |
Figure 10‑1: Interventional Coronary Catheter Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 10‑2: Interventional Coronary Catheter Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 10‑3: Guiding Catheter Market, Europe, 2019 – 2029 |
Figure 10‑4: Units Sold by Country, Guiding Catheter Market, Europe, 2019 – 2029 |
Figure 10‑5: Average Selling Price by Country, Guiding Catheter Market, Europe, 2019 – 2029 (€) |
Figure 10‑6: Average Selling Price by Country, Guiding Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 10‑7: Market Value by Country, Guiding Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 10‑8: Market Value by Country, Guiding Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 10‑9: Extension Guide Catheter Market, Europe, 2019 – 2029 |
Figure 10‑10: Units Sold by Country, Extension Guide Catheter Market, Europe, 2019 – 2029 |
Figure 10‑11: Average Selling Price by Country, Extension Guide Catheter Market, Europe, 2019 – 2029 (€) |
Figure 10‑12: Average Selling Price by Country, Extension Guide Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 10‑13: Market Value by Country, Extension Guide Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 10‑14: Market Value by Country, Extension Guide Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 10‑15: Leading Competitors, Interventional Coronary Catheter Market, Europe, 2022 |
Figure 10‑16: Leading Competitors by Country, Guiding Catheter Market, Europe, 2022 |
Figure 11‑1: Interventional Coronary Guidewire Market, Europe, 2019 – 2029 |
Figure 11‑2: Units Sold by Country, Interventional Coronary Guidewire Market, Europe, 2019 – 2029 |
Figure 11‑3: Average Selling Price by Country, Interventional Coronary Guidewire Market, Europe, 2019 – 2029 (€) |
Figure 11‑4: Average Selling Price by Country, Interventional Coronary Guidewire Market, Europe, 2019 – 2029 (US$) |
Figure 11‑5: Market Value by Country, Interventional Coronary Guidewire Market, Europe, 2019 – 2029 (€M) |
Figure 11‑6: Market Value by Country, Interventional Coronary Guidewire Market, Europe, 2019 – 2029 (US$M) |
Figure 11‑7: Leading Competitors by Country, Interventional Coronary Guidewire Market, Europe, 2022 |
Figure 12‑1: Coronary Embolic Protection Device Market, Europe, 2019 – 2029 |
Figure 12‑2: Units Sold by Country, Coronary Embolic Protection Device Market, Europe, 2019 – 2029 |
Figure 12‑3: Average Selling Price by Country, Coronary Embolic Protection Device Market, Europe, 2019 – 2029 (€) |
Figure 12‑4: Average Selling Price by Country, Coronary Embolic Protection Device Market, Europe, 2019 – 2029 (US$) |
Figure 12‑5: Market Value by Country, Coronary Embolic Protection Device Market, Europe, 2019 – 2029 (€M) |
Figure 12‑6: Market Value by Country, Coronary Embolic Protection Device Market, Europe, 2019 – 2029 (US$M) |
Figure 12‑7: Leading Competitors, Coronary Embolic Protection Device Market, Europe, 2022 |
Figure 13‑1: Coronary Atherectomy and Intravascular Lithotripsy Device Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 13‑2: Coronary Atherectomy and Intravascular Lithotripsy Device Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 13‑3: Coronary Atherectomy and Intravascular Lithotripsy Device Market, Europe, 2019 – 2029 |
Figure 13‑4: Mechanical Atherectomy Device Market, Europe, 2019 – 2029 |
Figure 13‑5: Units Sold by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 |
Figure 13‑6: Average Selling Price by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (€) |
Figure 13‑7: Average Selling Price by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (US$) |
Figure 13‑8: Market Value by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (€M) |
Figure 13‑9: Market Value by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (US$M) |
Figure 13‑10: Laser Atherectomy Device Market, Europe, 2019 – 2029 |
Figure 13‑11: Units Sold by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 |
Figure 13‑12: Average Selling Price by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (€) |
Figure 13‑13: Average Selling Price by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (US$) |
Figure 13‑14: Market Value by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (€M) |
Figure 13‑15: Market Value by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (US$M) |
Figure 13‑16: Intravascular Lithotripsy (IVL) Device Market, Europe, 2019 – 2029 |
Figure 13‑17: Leading Competitors, Coronary Atherectomy and Intravascular Lithotripsy Device Market, Europe, 2022 |
Figure 14‑1: Coronary CTO Guidewire Market, Europe, 2019 – 2029 |
Figure 14‑2: Units Sold by Country, Coronary CTO Guidewire Market, Europe, 2019 – 2029 |
Figure 14‑3: Average Selling Price by Country, Coronary CTO Guidewire Market, Europe, 2019 – 2029 (€) |
Figure 14‑4: Average Selling Price by Country, Coronary CTO Guidewire Market, Europe, 2019 – 2029 (US$) |
Figure 14‑5: Market Value by Country, Coronary CTO Guidewire Market, Europe, 2019 – 2029 (€M) |
Figure 14‑6: Market Value by Country, Coronary CTO Guidewire Market, Europe, 2019 – 2029 (US$M) |
Figure 14‑7: Leading Competitors, Coronary CTO Guidewire Market, Europe, 2022 |
Figure 15‑1: Coronary Introducer Sheath Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 15‑2: Coronary Introducer Sheath Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 15‑3: Coronary Introducer Sheath Market, Europe, 2019 – 2029 |
Figure 15‑4: Units Sold by Country, Coronary Introducer Sheath Market, Europe, 2019 – 2029 |
Figure 15‑5: Average Selling Price by Country, Coronary Introducer Sheath Market, Europe, 2019 – 2029 (€) |
Figure 15‑6: Average Selling Price by Country, Coronary Introducer Sheath Market, Europe, 2019 – 2029 (US$) |
Figure 15‑7: Market Value by Country, Coronary Introducer Sheath Market, Europe, 2019 – 2029 (€M) |
Figure 15‑8: Market Value by Country, Coronary Introducer Sheath Market, Europe, 2019 – 2029 (US$M) |
Figure 15‑9: Radial Introducer Sheath Market, Europe, 2019 – 2029 |
Figure 15‑10: Units Sold by Country, Radial Introducer Sheath Market, Europe, 2019 – 2029 |
Figure 15‑11: Average Selling Price by Country, Radial Introducer Sheath Market, Europe, 2019 – 2029 (€) |
Figure 15‑12: Average Selling Price by Country, Radial Introducer Sheath Market, Europe, 2019 – 2029 (US$) |
Figure 15‑13: Market Value by Country, Radial Introducer Sheath Market, Europe, 2019 – 2029 (€M) |
Figure 15‑14: Market Value by Country, Radial Introducer Sheath Market, Europe, 2019 – 2029 (US$M) |
Figure 15‑15: Femoral Introducer Sheath Market, Europe, 2019 – 2029 |
Figure 15‑16: Units Sold by Country, Femoral Introducer Sheath Market, Europe, 2019 – 2029 |
Figure 15‑17: Average Selling Price by Country, Femoral Introducer Sheath Market, Europe, 2019 – 2029 (€) |
Figure 15‑18: Average Selling Price by Country, Femoral Introducer Sheath Market, Europe, 2019 – 2029 (US$) |
Figure 15‑19: Market Value by Country, Femoral Introducer Sheath Market, Europe, 2019 – 2029 (€M) |
Figure 15‑20: Market Value by Country, Femoral Introducer Sheath Market, Europe, 2019 – 2029 (US$M) |
Figure 15‑21: Leading Competitors, Coronary Introducer Sheath Market, Europe, 2022 |
Figure 16‑1: Coronary Vascular Closure Device Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 16‑2: Coronary Vascular Closure Device Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 16‑3: Coronary Vascular Closure Device Market, Europe, 2019 – 2029 |
Figure 16‑4: Units Sold by Country, Coronary Vascular Closure Device Market, Europe, 2019 – 2029 |
Figure 16‑5: Average Selling Price by Country, Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (€) |
Figure 16‑6: Average Selling Price by Country, Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (US$) |
Figure 16‑7: Market Value by Country, Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (€M) |
Figure 16‑8: Market Value by Country, Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) |
Figure 16‑9: Radial Coronary Vascular Closure Device Market, Europe, 2019 – 2029 |
Figure 16‑10: Units Sold by Country, Radial Coronary Vascular Closure Device Market, Europe, 2019 – 2029 |
Figure 16‑11: Average Selling Price by Country, Radial Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (€) |
Figure 16‑12: Average Selling Price by Country, Radial Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (US$) |
Figure 16‑13: Market Value by Country, Radial Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (€M) |
Figure 16‑14: Market Value by Country, Radial Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) |
Figure 16‑15: Femoral Coronary Vascular Closure Device Market, Europe, 2019 – 2029 |
Figure 16‑16: Units Sold by Country, Femoral Coronary Vascular Closure Device Market, Europe, 2019 – 2029 |
Figure 16‑17: Average Selling Price by Country, Femoral Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (€) |
Figure 16‑18: Average Selling Price by Country, Femoral Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (US$) |
Figure 16‑19: Market Value by Country, Femoral Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (€M) |
Figure 16‑20: Market Value by Country, Femoral Coronary Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) |
Figure 16‑21: Leading Competitors, Coronary Vascular Closure Device Market, Europe, 2022 |
Figure 17‑1: Diagnostic Coronary Catheter and Guidewire Market by Segment, Europe, 2019 – 2029 (€M) |
Figure 17‑2: Diagnostic Coronary Catheter and Guidewire Market by Segment, Europe, 2019 – 2029 (US$M) |
Figure 17‑3: Diagnostic Coronary Catheter Market, Europe, 2019 – 2029 |
Figure 17‑4: Units Sold by Country, Diagnostic Coronary Catheter Market, Europe, 2019 – 2029 |
Figure 17‑5: Average Selling Price by Country, Diagnostic Coronary Catheter Market, Europe, 2019 – 2029 (€) |
Figure 17‑6: Average Selling Price by Country, Diagnostic Coronary Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 17‑7: Market Value by Country, Diagnostic Coronary Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 17‑8: Market Value by Country, Diagnostic Coronary Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 17‑9: Diagnostic Coronary Guidewire Market, Europe, 2019 – 2029 |
Figure 17‑10: Units Sold by Country, Diagnostic Coronary Guidewire Market, Europe, 2019 – 2029 |
Figure 17‑11: Average Selling Price by Country, Diagnostic Coronary Guidewire Market, Europe, 2019 – 2029 (€) |
Figure 17‑12: Average Selling Price by Country, Diagnostic Coronary Guidewire Market, Europe, 2019 – 2029 (US$) |
Figure 17‑13: Market Value by Country, Diagnostic Coronary Guidewire Market, Europe, 2019 – 2029 (€M) |
Figure 17‑14: Market Value by Country, Diagnostic Coronary Guidewire Market, Europe, 2019 – 2029 (US$M) |
Figure 17‑15: Fractional Flow Reserve Guidewire Market, Europe, 2019 – 2029 |
Figure 17‑16: Units Sold by Country, Fractional Flow Reserve Guidewire Market, Europe, 2019 – 2029 |
Figure 17‑17: Average Selling Price by Country, Fractional Flow Reserve Guidewire Market, Europe, 2019 – 2029 (€) |
Figure 17‑18: Average Selling Price by Country, Fractional Flow Reserve Guidewire Market, Europe, 2019 – 2029 (US$) |
Figure 17‑19: Market Value by Country, Fractional Flow Reserve Guidewire Market, Europe, 2019 – 2029 (€M) |
Figure 17‑20: Market Value by Country, Fractional Flow Reserve Guidewire Market, Europe, 2019 – 2029 (US$M) |
Figure 17‑21: Leading Competitors, Diagnostic Coronary Catheter and Guidewire Market, Europe, 2022 |
Figure 18‑1: Coronary IVUS Catheter Market, Europe, 2019 – 2029 |
Figure 18‑2: Units Sold by Country, Coronary IVUS Catheter Market, Europe, 2019 – 2029 |
Figure 18‑3: Average Selling Price by Country, Coronary IVUS Catheter Market, Europe, 2019 – 2029 (€) |
Figure 18‑4: Average Selling Price by Country, Coronary IVUS Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 18‑5: Market Value by Country, Coronary IVUS Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 18‑6: Market Value by Country, Coronary IVUS Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 18‑7: Leading Competitors, Coronary IVUS Catheter Market, Europe, 2022 |
Figure 19‑1: Coronary OCT Catheter Market, Europe, 2019 – 2029 |
Figure 19‑2: Units Sold by Country, Coronary OCT Catheter Market, Europe, 2019 – 2029 |
Figure 19‑3: Average Selling Price by Country, Coronary OCT Catheter Market, Europe, 2019 – 2029 (€) |
Figure 19‑4: Average Selling Price by Country, Coronary OCT Catheter Market, Europe, 2019 – 2029 (US$) |
Figure 19‑5: Market Value by Country, Coronary OCT Catheter Market, Europe, 2019 – 2029 (€M) |
Figure 19‑6: Market Value by Country, Coronary OCT Catheter Market, Europe, 2019 – 2029 (US$M) |
Figure 19‑7: Leading Competitors, Coronary OCT Market, Europe, 2022 |